Salvinorin A Novel Analog

About NeuroKappa Therapeutics

NeuroKappa Therapeutics is a preclinical-stage biotech leveraging kappa opioid receptor (KOR) pharmacology to develop novel treatments for stroke, pain, addiction, and depression. Its core strategy involves repurposing or optimizing known compounds like Dezocine and Salvinorin A analogs, with a focus on intranasal delivery to improve accessibility in emergency and non-hospital settings. The company is led by a team with extensive experience in opioid research and drug development but faces the challenges typical of an early-stage venture, including securing funding and demonstrating clinical proof-of-concept for its novel mechanisms.

Therapeutic Areas